查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1650698

全球静脉注射液市场

Intravenous (IV) Solutions
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 487 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球静脉注射液市场规模将达到 217 亿美元

2024 年全球静脉注射液市场规模估计为 141 亿美元，预计到 2030 年将达到 217 亿美元，2024-2030 年分析期间的复合年增长率为 7.5%。报告中分析的一个细分领域是肠外营养，预计分析期结束时复合年增长率为 7.9%，达到 151 亿美元。在分析期内，週边肠外营养部分预计将以 6.7% 的复合年增长率成长。

美国市场规模估计为 55 亿美元，中国市场预估年复合成长率为 9.0%

预计 2024 年美国静脉注射液市场价值将达 55 亿美元。中国是世界第二大经济体，预计到 2030 年市场规模将达到 22 亿美元，2024-2030 年分析期间的复合年增长率为 9.0%。其他值得注意的区域市场包括日本和加拿大，预计在分析期间的复合年增长率分别为 6.4% 和 7.2%。在欧洲，预计德国的复合年增长率约为 7.5%。

全球静脉注射解决方案市场 - 主要趋势和驱动因素摘要

静脉输液是现代医学的基石，它提供了一种将液体、药物和营养物质直接输送到血液中的方法。当无法口服或口服摄取不足时，这些液体对于维持体液平衡、电解质水平以及提供药物和必需营养素至关重要。依其成分及用途，液体分为晶体、胶体、血液製品、营养液等。晶体溶液，例如生理食盐水或乳酸林格氏液，最常用于復苏和维持液体水平。白蛋白和聚葡萄糖等胶体可用于扩大液体量。对于需要肠外营养的患者，提供碳水化合物、蛋白质和脂肪的营养液至关重要。这些解决方案的具体组成和管理都是根据患者的具体需求量身定制的，使其在从紧急护理到慢性病管理等各种医疗保健环境中都必不可少。

静脉注射液市场的成长受到多种因素的推动。糖尿病、癌症和胃肠道疾病等慢性疾病的发生率不断上升，推动了对液体疗法的需求，而液体疗法对于治疗这些疾病至关重要。由于老化社会容易出现脱水和营养不良，且老年患者经常需要静脉输液来保持水分和营养，因此市场正在进一步扩张。此外，随着外科手术和急诊护理的增多，需要可靠的液体供应以用于手术全期和急性护理。输液设备的技术进步和专门药物产品的开发扩大了输液治疗在各种临床环境中的使用。此外，人们对居家医疗和门诊护理的日益关注推动了对便携且易于管理的输液产品的需求，为患者的治疗方法提供了灵活性和便利性。总的来说，这些因素支撑了输液解决方案市场在医疗保健产业的强劲成长和重要性。

技术进步和严格的品质标准大大提高了输液的安全性和有效性。现代输液疗法融合了多种先进技术，例如改进的无菌技术、防止污染的先进包装以及开发预混溶液以最大限度地减少製备错误。智慧输液帮浦等技术创新彻底改变了液体管理，可以精确控制输液的速度和量，降低液体输注过量或不足的风险。此外，电子健康记录(EHR) 和输液系统的整合可以准确记录和监控静脉治疗，从而提高患者的安全性。製药业不断创新，开发新的配方和组合输液解决方案，以解决复杂的疾病状况、改善患者治疗效果并扩大输液治疗的治疗应用。

部分

类型（肠外营养、週边肠外营养）；营养素（单剂量胺基酸、维生素和矿物质、碳水化合物、肠外脂肪乳剂、其他营养素）

受访公司范例（82家值得关注的公司）

  • Amanta Healthcare Ltd.
  • Anhui Medipharm Co., Ltd.
  • AxaParenterals Ltd.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Fresenius Kabi AG
  • Grifols, SA
  • ICU Medical, Inc.
  • JW Life Science
  • Otsuka Pharmaceutical Co. Ltd.
  • Pfizer Inc.
  • Salius Pharma Private Limited.
  • Vifor Pharma Management Ltd.

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章 市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲国家
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 竞赛

简介目录
Product Code: MCP22111

Global Intravenous (IV) Solutions Market to Reach US$21.7 Billion by 2030

The global market for Intravenous (IV) Solutions estimated at US$14.1 Billion in the year 2024, is expected to reach US$21.7 Billion by 2030, growing at a CAGR of 7.5% over the analysis period 2024-2030. Parenteral Nutrition, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$15.1 Billion by the end of the analysis period. Growth in the Peripheral Parenteral Nutrition segment is estimated at 6.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$5.5 Billion While China is Forecast to Grow at 9.0% CAGR

The Intravenous (IV) Solutions market in the U.S. is estimated at US$5.5 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.2 Billion by the year 2030 trailing a CAGR of 9.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.4% and 7.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.5% CAGR.

Global Intravenous (IV) Solutions Market - Key Trends & Drivers Summarized

Intravenous (IV) solutions are a cornerstone of modern medical treatment, providing a direct method of delivering fluids, medications, and nutrients into the bloodstream. These solutions are crucial for maintaining fluid balance, electrolyte levels, and for delivering drugs and essential nutrients in situations where oral intake is not possible or insufficient. IV solutions are categorized based on their composition and purpose, such as crystalloids, colloids, blood products, and nutrient solutions. Crystalloids, like saline and lactated Ringer's, are the most commonly used for fluid resuscitation and maintenance. Colloids, including albumin and dextran, are used for volume expansion. Nutrient solutions, which provide carbohydrates, proteins, and fats, are vital for patients requiring parenteral nutrition. The precise composition and administration of these solutions are tailored to meet the specific needs of patients, making them indispensable in various medical settings, from emergency care to chronic disease management.

The growth in the intravenous (IV) solutions market is driven by several factors. The increasing prevalence of chronic diseases such as diabetes, cancer, and gastrointestinal disorders has heightened the demand for IV therapy, which is often essential for managing these conditions. The aging population, with its higher susceptibility to dehydration and nutrient deficiencies, further propels the market, as elderly patients frequently require IV solutions for hydration and nutritional support. Additionally, the rise in surgical procedures and emergency care incidences necessitates a reliable supply of IV solutions for perioperative care and acute treatment. Technological advancements in IV equipment and the development of specialized formulations have expanded the use of IV therapy in various clinical settings. Moreover, the growing focus on home healthcare and outpatient services has increased the demand for portable and easy-to-administer IV solutions, providing patients with greater flexibility and convenience in their treatment regimens. These factors collectively underscore the robust expansion and critical importance of the IV solutions market in the healthcare industry.

Technological advancements and rigorous quality standards have significantly improved the safety and efficacy of IV solutions. Modern IV therapy incorporates advancements such as improved sterility practices, enhanced packaging to prevent contamination, and the development of pre-mixed solutions to minimize preparation errors. Innovations like smart infusion pumps have revolutionized the administration of IV solutions, allowing for precise control over infusion rates and volumes, reducing the risk of over-infusion or under-infusion. Additionally, the integration of electronic health records (EHR) with infusion systems ensures accurate documentation and monitoring of IV therapy, enhancing patient safety. The pharmaceutical industry continues to innovate by developing new formulations and combinations of IV solutions to address complex medical conditions, improving patient outcomes and expanding the therapeutic applications of IV therapy.

SCOPE OF STUDY:

The report analyzes the Intravenous (IV) Solutions market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Parenteral Nutrition, Peripheral Parenteral Nutrition); Nutrient (Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion, Other Nutrients)

Geographic Regions/Countries:

World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.

Select Competitors (Total 82 Featured) -

  • Amanta Healthcare Ltd.
  • Anhui Medipharm Co., Ltd.
  • AxaParenterals Ltd.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Fresenius Kabi AG
  • Grifols, S.A.
  • ICU Medical, Inc.
  • JW Life Science
  • Otsuka Pharmaceutical Co. Ltd.
  • Pfizer Inc.
  • Salius Pharma Private Limited.
  • Vifor Pharma Management Ltd.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Global Economic Update
    • Competition
    • Intravenous (IV) Solutions - Global Key Competitors Percentage Market Share in 2024 (E)
    • An Introduction to Intravenous (IV) Solutions
    • Types of Intravenous Solutions
    • Global Market Prospects & Outlook
    • TPN Emerges as the Largest Segment in the IV Solutions Market
    • Single Dose Amino Acid Solutions: The Major Nutrient Type
    • Developed Economies Lead, Developing Regions to Propel Future Growth
    • World Brands
    • Recent Market Activity
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Prominent Trends to Watch-For in Intravenous Solutions Arena
    • Intravenous Therapy Faces Supply Shortages in the US
    • Sudden Shortage of Sodium Chloride Solutions from COVID
    • Medical Plastic Shortages Add to the Supply Woes
    • Resources for Healthcare Providers
    • Aging Global Demography and Resultant Rise in Need for Nutrition Management Augurs Well for the Market Growth
    • Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
    • Elderly Population (65+ Years) as a % of Total Population by Developed, Less Developed and Least Developed Regions: 2019 & 2030
    • Growing Prevalence of Malnutrition in Hospitalized Patients to Fuel Need for IV Solutions
    • Daily Requirements for Adults (Male and Female) by Nutrient Type
    • Energy Requirements by Age and Gender
    • Intravenous Fluids: The Lifeblood of Modern Healthcare
    • Rising Prevalence of Chronic Diseases and Resultant Need for Additional Nutrition Enhances Need to Administer IV Solutions
    • Rising Cancer Incidence and Need for Nutritional Support
    • Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
    • Number of New Cancer Cases and Deaths (in Million) by Region for 2020
    • Alarming Rise in Diabetes Incidence Worldwide
    • World Diabetes and Population Statistics (2019, 2030 & 2045)
    • World Diabetes Prevalence (2000-2045)
    • Global Prevalence of Diabetes: Number of Adults Diagnosed with Diabetes (in Million) by Gender for 2019, 2030 and 2045
    • Global Diabetes Mellitus Population Breakdown by Geographic Region: 2019, 2030 and 2045
    • Unrelenting Threat of HIV/AIDS Infection
    • Global HIV Prevalence: Number of People Living with AIDs (in Thousands) by Region for 2020
    • Number of AIDS-Related Deaths (in Thousands) by Region for 2018
    • Nutritional Management of Patients with Neurological Diseases
    • Burden of Neurological Diseases: Deaths Per 100,000 Population due to Neurological Conditions in Select Countries
    • Concerns over Fluid Depletion from Body Due to GI & Diarrheal Diseases Necessitate IV Fluid Administration
    • Growing Numbers of Pre-term Births Drives Demand for IV Solutions
    • Top Countries Ranked by Most Number of Preterm Births
    • Countries with Highest Preterm Birth Rates: Number of Preterm Births Per 100 Live Births by Top Countries
    • Demand Rises for Home Intravenous Nutritional Therapies
    • Premixed IV Nutrition: A Step towards Safer Medication Practices
    • Premixed Formulations Present Efficient Delivery System
    • Iron Replacement Therapies: Potential for Growth
    • Growing Demand for Low-Cost Intravenous Nutrition Solutions
    • Increasing Healthcare Expenditure Creates Conducive Environment
    • World Healthcare Expenditure (In US$ Trillion) for the Years for 2017, 2019, 2021 & 2023
    • Challenges Confronting IV Solutions Market
    • Issues with Traditional IV Tubing
    • Multi-Lumen IV Tubing to the Rescue
    • Innovative Multi-Lumen Tubing to Rethink IV Administration & Patient Experience
    • The Future of Smart Infusion Pumps for Intravenous Therapy Looks Bright
    • IV Solutions for Hypernatremia
    • Albumin (Human) Injection for Hypovolemia Treatment
    • Rising Focus on Blow-Fill-Seal Technology
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Intravenous (IV) Solutions Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Intravenous (IV) Solutions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Intravenous (IV) Solutions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Parenteral Nutrition by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Parenteral Nutrition by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Parenteral Nutrition by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Peripheral Parenteral Nutrition by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Peripheral Parenteral Nutrition by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Peripheral Parenteral Nutrition by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Single Dose Amino Acids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Single Dose Amino Acids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Single Dose Amino Acids by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Vitamins & Minerals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Vitamins & Minerals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Vitamins & Minerals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Carbohydrates by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Carbohydrates by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Carbohydrates by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Parenteral Lipid Emulsion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Parenteral Lipid Emulsion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Parenteral Lipid Emulsion by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other Nutrients by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other Nutrients by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Other Nutrients by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Intravenous (IV) Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2015, 2025 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2015, 2025 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2015, 2025 & 2030
  • JAPAN
    • Intravenous (IV) Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2015, 2025 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Japan 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2015, 2025 & 2030
  • CHINA
    • Intravenous (IV) Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2015, 2025 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: China 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2015, 2025 & 2030
  • EUROPE
    • Intravenous (IV) Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Intravenous (IV) Solutions by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Intravenous (IV) Solutions by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2015, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2015, 2025 & 2030
  • FRANCE
    • Intravenous (IV) Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2015, 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: France 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2015, 2025 & 2030
  • GERMANY
    • Intravenous (IV) Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2015, 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Germany 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2015, 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Italy 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Intravenous (IV) Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2015, 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: UK 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2015, 2025 & 2030
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Spain 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2015, 2025 & 2030
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Russia 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2015, 2025 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Intravenous (IV) Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Intravenous (IV) Solutions by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Intravenous (IV) Solutions by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2015, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Intravenous (IV) Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2015, 2025 & 2030
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Australia 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2015, 2025 & 2030
  • INDIA
    • Intravenous (IV) Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 116: India Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2015, 2025 & 2030
    • TABLE 119: India Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: India 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2015, 2025 & 2030
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: South Korea 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2015, 2025 & 2030
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Intravenous (IV) Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Intravenous (IV) Solutions by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Intravenous (IV) Solutions by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2015, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2015, 2025 & 2030
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Argentina 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2015, 2025 & 2030
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Brazil 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2015, 2025 & 2030
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Mexico 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2015, 2025 & 2030
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Intravenous (IV) Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Intravenous (IV) Solutions by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Intravenous (IV) Solutions by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2015, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2015, 2025 & 2030
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Iran 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2015, 2025 & 2030
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Israel 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2015, 2025 & 2030
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2015, 2025 & 2030
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: UAE 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2015, 2025 & 2030
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2015, 2025 & 2030
  • AFRICA
    • Intravenous (IV) Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2015, 2025 & 2030
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Africa 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2015, 2025 & 2030

IV. COMPETITION